[1]
A. . Jain, “Global Regulatory Frameworks, Manufacturing Complexities, and Clinical Implications of Biosimilar Biotherapeutics: An Integrated Analysis of Development, Evaluation, and Future Innovation”, lfmspj, vol. 6, no. 03, pp. 31–39, Mar. 2026.